Navigation Links
MINRAD International, Inc. Announces $40.0 Million Private Placement
Date:5/5/2008

Officer

ctrego@minrad.com

(716) 855-1068

http://www.minrad.com

About the Company

MINRAD International, Inc. is an interventional pain management company with real-time image guidance, anesthesia and analgesia, conscious sedation product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company's website, http://www.minrad.com.

The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Factors that may cause actual results to differ materially from those expressed or implied by its forward-looking statements include, but are not limited to, Minrad International's limited operating history and business development associated with being a growth stage company; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competitio
'/>"/>

SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
2. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
3. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
4. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
5. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
6. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
7. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
8. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
9. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
10. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
11. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Calif., Dec. 14 Vermillion, Inc. ... today announced William C. Wallen, Ph.D. Chief ... Development for IDEXX Laboratories, will be joining ... Vermillion,s bankruptcy plan. ,, "Bill brings ... experience in diagnostics and biotechnology," said Gail ...
(Date:12/14/2009)... The third edition of ... published by the Infusion Nurses Society (INS), ... extravasation.(1) Anthracyclines are a group of chemotherapy ... have been used in the treatment of various ... ,, According to the INS publication: "In ...
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
(Date:12/14/2009)... - Results From a Survey Conducted ... Seven Major Industrialized Countries , , - ... disease, impacts their enjoyment of ... rheumatoid arthritis find shopping for gifts, ... difficult to do, ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4
... Mass., Feb. 17 Idenix Pharmaceuticals, Inc. (Nasdaq: ... development of drugs for the treatment of human viral and ... fourth quarter and year ended December 31, 2008. At December ... $46.1 million. Business Highlights , , ...
... TechniKrom, Inc. and Asahi Kasei,Medical Co., Ltd., who ... for use with Planova(TM) virus removal filters,have reached ... Asahi Kasei Medical,s full ownership. The integration of,operations ... Kasei TechniKrom, Inc., a,wholly owned subsidiary of Asahi ...
... Inc., a biotechnology company delivering breakthrough therapies in ... is a SILVER level sponsor of the 2009 ... conference, put on by the Alzheimer,s Association, is ... 2009 will take place July 11-16 in Vienna, ...
Other Biology Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 7TechniKrom's Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical 2Accera, Inc. Sponsors Alzheimer's Association's 2009 ICAD Conference 2
(Date:12/15/2009)... available in German ., Despite the ... the globe, cultures vary as to how space is ... use egocentric terms such as ,left, right, front, back, ... like ,north, south, east, west, at all times for ... or "There is an snake by your Northern leg". ...
(Date:12/15/2009)... near future, consumers can look forward to ultra-low ... laptops, PDAs and mobile phones. This is made ... technologies which are critical elements for power optimisation ... systems. , Analog IC design is the key ... To pre-position the nation in advanced analog and ...
(Date:12/15/2009)... Va., Dec. 15 The PTR Group, a ... announced that it has agreed to sponsor three high ... FIRST Robotics Competition ( http://usfirst.org ). ,, ... school teams in three different states. The teams ... Rockwall, TX, and James Madison HS in Vienna, VA ...
Breaking Biology News(10 mins):More than a jump to the left 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Study Details Swine Flu Transmission Rates 55637 1Study Details Swine Flu Transmission Rates 55637 2Study Details Swine Flu Transmission Rates 55637 3America Needs More Physician Hospitals 55635 1America Needs More Physician Hospitals 55635 2New tool to predict the risk of death in COPD may help physicians to individualize treatment 55633 1New tool to predict the risk of death in COPD may help physicians to individualize treatment 55633 2
... National Human Genome Research Institute (NHGRI), part of the ... identified six more genetic variants involved in type 2 ... risk factors associated with increased risk of the disease. ... study had previously been suspected of playing a role ...
... ANN ARBOR, Mich.---Scientists have identified six new genes which play ... among the group is the second gene known to also ... bring the total number of genes or genomic regions implicated ... in the Department of Biostatistics. Researchers from the University of ...
... that can be applied in the study of other ... in collaboration with colleagues at the University of Washington ... have identified multiple, individually rare gene mutations in people ... illness is caused. , The team screened ...
Other Biology News:Major collaboration uncovers surprising new genetic clues to diabetes 2Major collaboration uncovers surprising new genetic clues to diabetes 3Potential association of type 2 diabetes genes with prostate cancer 2CSHL scientists part of team that discovers role of rare gene mutations in schizophrenia 2CSHL scientists part of team that discovers role of rare gene mutations in schizophrenia 3
... have been developed for affinity capture ... variety of ProteinChip chemical surfaces allow ... their unique biochemical properties. Each chip ... sample comparison, and the chips are ...
... arrays have been developed for affinity ... A variety of ProteinChip chemical surfaces ... to their unique biochemical properties. Each ... side-by-side sample comparison, and the chips ...
... preps Storage: The kit is stable for 12 ... all contents of the kit cold. , ... a silica-gel based membrane which selectively adsorbs up ... of specialized binding buffers. Nucleotides, oligos ( , ...
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
Biology Products: